| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.6B | $5.3B | $6.9B | $7.5B | $3.1B | $3.1B | $1.0B | $1.2B |
| Cost of Revenue | $1.5B | $1.9B | $2.2B | $2.1B | $1.9B | $1.7B | $1.8B | $1.7B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.3B | $0.2B | $0.3B | $0.2B | $0.2B | $0.3B | $0.3B |
| Operating Income | $3.2B | $0.7B | $2.3B | $2.7B | $-1.4B | $-0.9B | $-1.5B | $-0.6B |
| Net Income | $2.0B | $0.2B | $1.7B | $1.8B | $-1.2B | $-1.0B | $-1.2B | $-0.6B |
| EPS (Basic) | $3.33 | $0.45 | $4.56 | $4.79 | $-3.58 | — | $-4.79 | $-2.50 |
| EPS (Diluted) | $3.31 | $0.45 | $4.22 | $4.38 | $-3.58 | — | $-4.79 | $-2.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.8B | $39.8B | $25.3B | $22.7B | $21.6B | $18.1B | $18.8B | $20.7B |
| Current Assets | $1.9B | $1.7B | $2.0B | $4.0B | $2.3B | $1.2B | $1.8B | $2.0B |
| Cash & Equivalents | $0.1B | $0.2B | $0.1B | $1.5B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $14.4B | $15.6B | $10.5B | $11.5B | $11.6B | $8.9B | $9.0B | $9.8B |
| Current Liabilities | $2.5B | $2.5B | $2.0B | $3.7B | $5.1B | $1.8B | $1.3B | $2.4B |
| Stockholders' Equity | $23.8B | $20.6B | $14.8B | $11.2B | $10.0B | $9.3B | $9.8B | $11.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.1B | $2.8B | $3.2B | $3.5B | $1.7B | $1.5B | $1.9B | $3.0B |
| Investing Cash Flow | $-2.8B | $-1.6B | $-4.3B | $-1.4B | $-2.1B | $-1.6B | $-1.6B | $-4.0B |
| Capital Expenditures | $2.3B | $2.3B | $2.0B | $1.4B | $1.1B | $1.0B | $1.6B | $3.0B |
| Financing Cash Flow | $-2.4B | $-1.1B | $-0.2B | $-0.7B | $0.5B | $0.0B | $-0.2B | $0.9B |